SHOULDER INNOVATIONS, INC. Increase (Decrease) in Accounts Receivable
SHOULDER INNOVATIONS, INC. (SI) reported Increase (Decrease) in Accounts Receivable of $2.86 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $468.00K, a 29.64% increase year-over-year.
- SHOULDER INNOVATIONS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $2.39M, a 63.74% increase year-over-year.
- SHOULDER INNOVATIONS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $1.24M, a 86.88% increase year-over-year.
- SHOULDER INNOVATIONS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $240.00K, a 300.00% increase year-over-year.
- SHOULDER INNOVATIONS, INC. increase (decrease) in accounts receivable for fiscal 2025 was $3.30M, a 473.74% increase from fiscal 2024.
- SHOULDER INNOVATIONS, INC. increase (decrease) in accounts receivable for fiscal 2024 was $575.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $468.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.86M 10-Q · filed 2026-08-06 | $4.10M derived: sum of 3 quarters · filed 2026-08-06 | $4.34M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.39M 10-Q · filed 2026-05-13 | $3.63M derived: sum of 2 quarters · filed 2026-05-13 | $3.87M derived: sum of 3 quarters · filed 2026-05-13 | $4.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.48M derived: sum of 2 quarters · filed 2026-03-10 | $1.84M derived: sum of 3 quarters · filed 2026-08-06 | $3.30M 10-K · filed 2026-03-10 |
| 2025-09-30 | $240.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $601.00K derived: sum of 2 quarters · filed 2026-08-06 | $2.06M 10-Q · filed 2025-11-12 | $2.72M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $361.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.82M 10-Q · filed 2026-08-06 | $2.48M derived: sum of 3 quarters · filed 2026-08-06 | $2.54M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.46M 10-Q · filed 2026-05-13 | $2.12M derived: sum of 2 quarters · filed 2026-05-13 | $2.18M derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-31 | $663.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $723.00K derived: sum of 2 quarters · filed 2026-03-10 | $575.00K 10-K · filed 2026-03-10 | |
| 2024-09-30 | $60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$88.00K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | -$148.00K 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |